Literature DB >> 9764030

Bacterial factors and immune pathogenesis in Helicobacter pylori infection.

T Shimoyama1, J E Crabtree.   

Abstract

Virulent Helicobacter pylori strains which have been clinically associated with severe outcome induce increased gastric mucosal immune responses. Although several bacterial pathogenic factors have been shown to have a considerable role in H pylori infection, variability in host immune responses may also contribute to mucosal damage in H pylori associated gastritis.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9764030      PMCID： PMC1766604     

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  57 in total

1.  Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa.

Authors:  H A Haeberle; M Kubin; K B Bamford; R Garofalo; D Y Graham; F El-Zaatari; R Karttunen; S E Crowe; V E Reyes; P B Ernst
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Relation between T cell number and epithelial HLA class II expression quantified by image analysis in normal and inflamed human gastric mucosa.

Authors:  K Valnes; H S Huitfeldt; P Brandtzaeg
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

3.  Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only.

Authors:  N Figura; P Guglielmetti; A Rossolini; A Barberi; G Cusi; R A Musmanno; M Russi; S Quaranta
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

4.  Interaction of campylobacter species with antibody, complement and phagocytes.

Authors:  E Bernatowska; P Jose; H Davies; M Stephenson; D Webster
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

5.  Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

Authors:  J E Crabtree; J D Taylor; J I Wyatt; R V Heatley; T M Shallcross; D S Tompkins; B J Rathbone
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

6.  Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion.

Authors:  K Bodger; J I Wyatt; R V Heatley
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

7.  Low biological activity of Helicobacter pylori lipopolysaccharide.

Authors:  A Muotiala; I M Helander; L Pyhälä; T U Kosunen; A P Moran
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis.

Authors:  J E Crabtree; T M Shallcross; R V Heatley; J I Wyatt
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

9.  Gastric mucosal inflammatory responses to Helicobacter pylori.

Authors:  J E Crabtree
Journal:  Aliment Pharmacol Ther       Date:  1996-04       Impact factor: 8.171

10.  Cytotoxic activity in broth-culture filtrates of Campylobacter pylori.

Authors:  R D Leunk; P T Johnson; B C David; W G Kraft; D R Morgan
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472
View more
  24 in total

1.  Interweaving microRNAs and proinflammatory cytokines in gastric mucosa with reference to H. pylori infection.

Authors:  Hajime Isomoto; Kayoko Matsushima; Naoki Inoue; Tomayoshi Hayashi; Toshiyuki Nakayama; Masaki Kunizaki; Shigekazu Hidaka; Masaaki Nakayama; Junzo Hisatsune; Masahiro Nakashima; Takeshi Nagayasu; Kazuhiko Nakao; Toshiya Hirayama
Journal:  J Clin Immunol       Date:  2011-12-13       Impact factor: 8.317

2.  CXC chemokines Gro(alpha)/IL-8 and IP-10/MIG in Helicobacter pylori gastritis.

Authors:  M Eck; B Schmausser; K Scheller; A Toksoy; M Kraus; T Menzel; H K Müller-Hermelink; R Gillitzer
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

3.  Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agent.

Authors:  Ludwig Deml; Michael Aigner; Jochen Decker; Alexander Eckhardt; Christian Schütz; Peer R E Mittl; Sascha Barabas; Stefanie Denk; Gertrud Knoll; Norbert Lehn; Wulf Schneider-Brachert
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  High concentrations of human beta-defensin 2 in gastric juice of patients with Helicobacter pylori infection.

Authors:  Hajime Isomoto; Hiroshi Mukae; Hiroshi Ishimoto; Yoshito Nishi; Chun-Yang Wen; Akihiro Wada; Ken Ohnita; Toshiya Hirayama; Masamitsu Nakazato; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

5.  Characterization of the pilin ortholog of the Helicobacter pylori type IV cag pathogenicity apparatus, a surface-associated protein expressed during infection.

Authors:  Joanna Andrzejewska; Sae Kyung Lee; Patrick Olbermann; Nina Lotzing; Elena Katzowitsch; Bodo Linz; Mark Achtman; Clarence I Kado; Sebastian Suerbaum; Christine Josenhans
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

6.  Enhanced expression of CXCL13 in human Helicobacter pylori-associated gastritis.

Authors:  Yujiro Nakashima; Hajime Isomoto; Kayoko Matsushima; Akira Yoshida; Toshiyuki Nakayama; Masaaki Nakayama; Junzo Hisatsune; Tatsuki Ichikawa; Fuminao Takeshima; Tomayoshi Hayashi; Kazuhiko Nakao; Toshiya Hirayama; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2011-06-07       Impact factor: 3.199

7.  Colonization and inflammation deficiencies in Mongolian gerbils infected by Helicobacter pylori chemotaxis mutants.

Authors:  David J McGee; Melanie L Langford; Emily L Watson; J Elliot Carter; Yu-Ting Chen; Karen M Ottemann
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

8.  Clinical relevance of the number of interleukin-17-producing CD 8+ T cells in patients with gastric cancer.

Authors:  Hiroaki Saito; Yoshinori Yamada; Seigo Takaya; Tomohiro Osaki; Masahide Ikeguchi
Journal:  Surg Today       Date:  2015-04-14       Impact factor: 2.549

9.  Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review.

Authors:  Keiko Ando; Takashi Shimamoto; Tetsuzo Tauchi; Yoshikazu Ito; Yuzuru Kuriyama; Akihiko Gotoh; Keisuke Miyazawa; Yukihiko Kimura; Takashi Kawai; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

10.  Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection.

Authors:  R Rad; A Dossumbekova; B Neu; R Lang; S Bauer; D Saur; M Gerhard; C Prinz
Journal:  Gut       Date:  2004-08       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.